Strong activation of ether-à-go-go-related gene 1 K + channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells

Molecular Pharmacology

Volumn 80, Issue 5, 2011, Pages 930-942

  Schuster, Anna M ^a   Glassmeier, Günter ^a   Bauer, Christiane K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BIS (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL)UREA; NS 1643; POTASSIUM CHANNEL AFFECTING AGENT; POTASSIUM CHANNEL ERG1A; POTASSIUM CHANNEL ERG1B; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CHO CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN CELL; MEMBRANE CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS LAEVIS;

ANIMALS; CELL LINE; CHO CELLS; CRESOLS; CRICETINAE; CRICETULUS; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; PHENYLUREA COMPOUNDS; PROTEIN ISOFORMS; XENOPUS LAEVIS;

EID: 80054782112     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.071621     Document Type: Article

References (37)

1. + channel function in oocyte expression studies. J Biol Chem 278:11739-11745.
2. Bauer CK, Engeland B, Wulfsen I, Ludwig J, Pongs O, and Schwarz JR (1998) RERG is a molecular correlate of the inward-rectifying K current in clonal rat pituitary cells. Receptors Channels 6:19-29. (Pubitemid 28336946)
3. + channel-drug interactions by ancillary subunits. J Physiol 586:929-950.
4. Casis O, Olesen SP, and Sanguinetti MC (2006) Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol 69:658-665. (Pubitemid 43121963)
5. Cui J, Kagan A, Qin D, Mathew J, Melman YF, and McDonald TV (2001) Analysis of the cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE2. J Biol Chem 276:17244-17251.
6. Diness TG, Yeh YH, Qi XY, Chartier D, Tsuji Y, Hansen RS, Olesen SP, Grunnet M, and Nattel S (2008) Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. Cardiovasc Res 79:61-69. (Pubitemid 351881940)
7. Fermini B and Fossa AA (2003) The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2:439-447. (Pubitemid 37361725)
8. Gerlach AC, Stoehr SJ, and Castle NA (2010) Pharmacological removal of human ether-a-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574). Mol Pharmacol 77:58-68.
9. Gómez-Varela D, de la Peña P, García J, Giráldez T, and Barros F (2002) Influence of amino-terminal structures on kinetic transitions between several closed and open states in human erg K+ channels. J Membr Biol 187:117-133. (Pubitemid 34526477)
10. + channel activation by NS1643. Mol Pharmacol 79:1-9.
11. Grunnet M, Hansen RS, and Olesen SP (2008) hERG1 channel activators: a new anti-arrhythmic principle. Prog Biophys Mol Biol 98:347-362.
12. Guasti L, Cilia E, Crociani O, Hofmann G, Polvani S, Becchetti A, Wanke E, Tempia F, and Arcangeli A (2005) Expression pattern of the ether-a-go-go-related (ERG) family proteins in the adult mouse central nervous system: evidence for coassembly of different subunits. J Comp Neurol 491:157-174. (Pubitemid 41262866)
13. Hansen RS, Diness TG, Christ T, Demnitz J, Ravens U, Olesen SP, and Grunnet M (2006) Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol 69:266-277. (Pubitemid 43048913)
14. + currents in rat embryonic serotonergic neurones. J Physiol 564:33-49.
15. Kr channels minimally comprise hERG 1a and 1b subunits. J Biol Chem 279:44690-44694.
16. Killeen MJ, Thomas G, Olesen SP, Demnitz J, Stokoe KS, Grace AA, and Huang CL (2008) Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart. Acta Physiol (Oxf) 193:25-36. (Pubitemid 351490258)
17. + channels are dominated by the rerg1b subunit. J Physiol 571:27-42.
18. Larsen AP, Bentzen BH, and Grunnet M (2010) Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels. Br J Pharmacol 161:614-628.
19. + channel in mouse and human hearts. Circ Res 81:719-726.
20. Li GR and Dong MQ (2010) Pharmacology of cardiac potassium channels. Adv Pharmacol 59:93-134.
21. London B, Trudeau MC, Newton KP, Beyer AK, Copeland NG, Gilbert DJ, Jenkins NA, Satler CA, and Robertson GA (1997) Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ Res 81:870-878. (Pubitemid 27467223)
22. Lu HR, Vlaminckx E, Hermans AN, Rohrbacher J, Van Ammel K, Towart R, Pugsley M, and Gallacher DJ (2008) Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines. Br J Pharmacol 154:1427-1438.
23. + channels modulate contractile activity in the bovine epididymal duct. Am J Physiol Regul Integr Comp Physiol 294:R895-R904.
24. Mullins FM, Stepanovic SZ, Desai RR, George AL Jr, and Balser JR (2002) Extracellular sodium interacts with the HERG channel at an outer pore site. J Gen Physiol 120:517-537. (Pubitemid 35155094)
25. Numaguchi H, Johnson JP Jr, Petersen CI, and Balser JR (2000) A sensitive mechanism for cation modulation of potassium current. Nat Neurosci 3:429-430. (Pubitemid 30495621)
26. Perry M and Sanguinetti MC (2008) A single amino acid difference between ether-a-go-go-related gene channel subtypes determines differential sensitivity to a small molecule activator. Mol Pharmacol 73:1044-1051. (Pubitemid 351439186)
27. Polak S, Wiśniowska B, and Brandys J (2009) Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties. J Appl Toxicol 29:183-206.
28. Sanguinetti MC, Jiang C, Curran ME, and Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299-307.
29. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215.
30. Schönherr R and Heinemann SH (1996) Molecular determinants for activation and inactivation of HERG, a human inward rectifier potassium channel. J Physiol 493:635-642. (Pubitemid 26232101)
31. + channels in excitable cells. J Cell Mol Med 8:22-30.
32. Trudeau MC, Warmke JW, Ganetzky B, and Robertson GA (1995) HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269:92-95.
33. Wang S, Liu S, Morales MJ, Strauss HC, and Rasmusson RL (1997) A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes. J Physiol 502:45-60. (Pubitemid 27322975)
34. Warmke JW and Ganetzky B (1994) A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 91:3438-3442. (Pubitemid 24130252)
35. Weerapura M, Nattel S, Chartier D, Caballero R, and Hébert TE (2002) A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? J Physiol 540:15-27. (Pubitemid 35174983)
36. + channels expressed in mammalian cell lines and Xenopus oocytes. J Pharmacol Toxicol Methods 48:65-80.
37. Xu X, Recanatini M, Roberti M, and Tseng GN (2008) Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243). Mol Pharmacol 73:1709-1721. (Pubitemid 351724359)